TEVA
Teva Pharma Industries Ltd
36.50$
-0.6%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +23,580.0% | -110.5% | – | +572.8% | -17.0% | -118.3% | – | +62.6% | +213.8% | -103.5% | – | – | |
| – | -6.0% | +2.3% | -4.8% | +0.0% | +3.9% | -9.3% | +2.9% | -0.8% | +4.4% | -8.1% | +0.8% | – | |
| – | -9.7% | +0.0% | +14.3% | -9.4% | +17.2% | +0.0% | +11.8% | -10.5% | +50.0% | -15.7% | -7.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -252.5% | – | – | -177.3% | – | – | – | – | -369.4% | – | – | |
| – | -20.1% | +4.2% | -21.8% | +52.6% | -12.8% | -1.6% | -24.4% | +41.7% | +4.4% | +18.3% | -38.1% | – | |
| – | +63.6% | -52.2% | +23.6% | +50.6% | -24.6% | -0.5% | +17.4% | -42.8% | +22.2% | +38.8% | -314.4% | – | |
| – | – | – | – | – | – | +99.7% | – | -9,120.0% | -100.0% | – | -100.0% | – | |
| – | +0.0% | -73.8% | +539.7% | -100.0% | – | +158.8% | – | -7,650.0% | – | -67.5% | -107.7% | – | |
| – | – | -124.2% | – | – | -101.8% | – | – | -90.9% | +3,121.4% | -86.3% | -146.5% | – | |
| – | – | -123.3% | – | +8,983.3% | -18.2% | -152.0% | – | +77.9% | +336.1% | -120.5% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.